Vascular effects of ultrafine particles in persons with type 2 diabetes

Environmental Health Perspectives

Volumn 118, Issue 12, 2010, Pages 1692-1698

  Stewart, Judith C ^a   Chalupa, David C ^a   Devlin, Robert B ^b   Frasier, Lauren M ^a   Huang, Li Shan ^a   Little, Erika L ^a   Lee, Steven M ^a   Phipps, Richard P ^a   Pietropaoli, Anthony P ^a   Taubman, Mark B ^a   Utell, Mark J ^a   Frampton, Mark W ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Air pollution; Diabetes; Platelets; Ultrafne particles; Vascular

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; CARBON; CD40 LIGAND; D DIMER; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

ADULT; AIR POLLUTION; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THROMBOCYTE; VASCULAR ENDOTHELIUM;

ADULT; AGE FACTORS; AIR POLLUTANTS; BLOOD VESSELS; CARBON; CD40 LIGAND; COAGULANTS; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PARTICULATE MATTER; SEX FACTORS; SYSTEMIC VASCULITIS; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 78650294588     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1002237     Document Type: Article

References (58)

1. Alberti KG, Zimmet PZ. 1998. Defnition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: diagnosis and classifcation of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 15:539-553.
2. Beckett WS, Chalupa DF, Pauly-Brown A, Speers DM, Stewart JC, Frampton MW, et al. 2005. Comparing inhaled ultrafne versus fne zinc oxide particles in healthy adults: a human inhalation study. Am J Respir Crit Care Med 171:1129-1135.
3. Brook RD, Jerrett M, Brook JR, Bard RL, Finkelstein MM. 2008. The relationship between diabetes mellitus and traffic-related air pollution. J Occup Environ Med 50:32-38.
4. Carlsten C, Kaufman JD, Peretz A, Trenga CA, Sheppard L, Sullivan JH. 2007. Coagulation markers in healthy human subjects exposed to diesel exhaust. Thromb Res 120:849-855.
5. Chalupa DC, Gibb FR, Morrow PE, Oberdorster G, Riesenfeld E. 2002. A facility for controlled human exposures to ultra-fne particles. In: Crucial Issues in Inhalation Research-Mechanistic, Clinical and Epidemiologic (Heinrich U, Mohr U, eds). Washington, DC:ILSI Press, 241-253.
6. Chalupa DC, Morrow PE, Oberdörster G, Utell MJ, Frampton MW. 2004. Ultrafne particle deposition in subjects with asthma. Environ Health Perspect 112:879-882.
7. Daigle CC, Chalupa DC, Gibb FR, Morrow PE, Oberdorster G, Utell MJ, et al. 2003. Ultrafine particle deposition in humans during rest and exercise. Inhal Toxicol 15:539-552.
8. Delfno RJ, Staimer N, Tjoa T, Polidori A, Arhami M, Gillen DL, et al. 2008. Circulating biomarkers of infammation, antioxi-dant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease. Environ Health Perspect 116:898-906.
9. Dubowsky SD, Suh H, Schwartz J, Coull BA, Gold DR. 2006. Diabetes, obesity, and hypertension may enhance associations between air pollution and markers of systemic infammation. Environ Health Perspect 114:992-998.
10. Frampton MW, Stewart JC, Oberdörster G, Morrow PE, Chalupa D, Pietropaoli A P, et al. 2006. Inhalation of ultrafne particles alters blood leukocyte expression of adhesion molecules in humans. Environ Health Perspect 114:51-58.
11. Frampton MW, Stewart JC, Pietropaoli A P, Oberdörster G, Zareba W, Chalupa D, et al. 2007. Ultrafne Carbon particle inhalation in subjects with type 2 diabetes [Abstract]. Am J Respir Crit Care Med 175:A168.
12. Frampton MW, Utell MJ. 2000. Cardiopulmonary consequences of particle inhalation. In: Particle-Lung Interactions (Gehr P, Heyder J, eds). New York:Marcel Dekker, Inc., 653-670.
13. Freedman JE, Loscalzo J. 2002. Platelet-monocyte aggregates: bridging thrombosis and infammation. Circulation 105:2130-2132.
14. Garlichs CD, Eskafi S, Raaz D, Schmidt A, Ludwig J, Herrmann M, et al. 2001. Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. Heart 86:649-655.
15. Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schulz H, et al. 2005. Ultrafne particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 113:1555-1560.
16. Goldberg MS, Burnett RT, Yale JF, Valois MF, Brook JR. 2006. Associations between ambient air pollution and daily mortality among persons with diabetes and cardiovascular disease. Environ Res 100:255-267.
17. HEI Panel on the Health Effects of Traffc-Related Air Pollution. 2010. Traffc-Related Air Pollution: A Critical Review of the Literature on Emissions, Exposure, and Health Effects. Boston, MA:Health Effects Institute.
18. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, et al. 1998. CD40 ligand on activated platelets triggers an infammatory reaction of endothelial cells. Nature 391:591-594.
19. Horii M, Uemura S, Uemura M, Matsumoto M, Ishizashi H, Imagawa K, et al. 2008. Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation. Heart Vessels 23:301-307.
20. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS. 2003. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 109:175-180.
21. Jones B, Kenward MG. 2003. Design and Analysis of CrossOver Trials. London:Chapmand and Hall.
22. Khorana AA, Francis CW, Menzies KE, Wang JG, Hyrien O, Hathcock J, et al. 2008. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost 6:1983-1985.
23. Kittleson DB, Watts WF, Johnson J P. 2004. Nanoparticle emissions on Minnesota highways. Atmos Environ 38:9-19.
24. Lee KW, Lip GY, Tayebjee M, Foster W, Blann AD. 2005. Circulating endothelial cells, von Willebrand factor, inter-leukin-6, and prognosis in patients with acute coronary syndromes. Blood 105:526-532.
25. Li N, Goodall AH, Hjemdahl P. 1999. Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fuorescence signal triggering. Cytometry 35:154-161.
26. Liao D, Heiss G, Chinchilli VM, Duan Y, Folsom AR, Lin HM, et al. 2005. Association of criteria pollutants with plasma hemo-static/inflammatory markers: a population-based study. J Expo Anal Environ Epidemiol 15:319-328.
27. Lim HS, Blann AD, Lip GY. 2004. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention. Circulation 109:2524-2528.
28. Lucking AJ, Lundback M, Mills NL, Faratian D, Barath SL, Pourazar J, et al. 2008. Diesel exhaust inhalation increases thrombus formation in man. Eur Heart J 29:3043-3051.
29. Mason PJ, Chakrabarti S, Albers AA, Rex S, Vitseva O, Varghese S, et al. 2005. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease. Am J Cardiol 96:1365-1369.
30. McDonald JD, Powell QH, Bowen LE, Mauderly JL. 2001. Organic carbon content of aerosols produced from a Palas carbon generation system [Abstract]. Toxicologist 60:460.
31. Mills NL, Robinson SD, Fokkens PHB, Leseman DLA, Miller MR, Anderson D, et al. 2008. Exposure to concentrated ambient particles does not affect vascular function in patients with coronary heart disease. Environ Health Perspect 116:709-715.
32. Mills NL, Tornqvist H, Gonzalez MC, Vink E, Robinson SD, Soderberg S, et al. 2007. Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease. N Engl J Med 357:1075-1082.
33. Mills NL, Tornqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, et al. 2005. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fbrinoly-sis. Circulation 112:3930-3936.
34. Montalescot G, Philippe F, Ankri A, Vicaut E, Bearez E, Poulard JE, et al. 1998. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: benefcial effects of enoxaparin. Circulation 98:294-299.
35. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, et al. 2006. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 26:2594-2604.
36. Nemmar A, Hoylaerts MF, Nemery B. 2006. Effects of particu-late air pollution on hemostasis. Clin Occup Environ Med 5:865-881.
37. O'Neill MS, Veves A, Sarnat JA, Zanobetti A, Gold DR, Economides PA, et al. 2007. Air pollution and infammation in type 2 diabetes: a mechanism for susceptibility. Occup Environ Med 64:373-379.
38. O'Neill MS, Veves A, Zanobetti A, Sarnat JA, Gold DR, Panayiotis A, et al. 2005. Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation 111:2913-2920.
39. Peretz A, Sullivan JH, Leotta DF, Trenga CA, Sands FN, Allen J, et al. 2008. Diesel exhaust inhalation elicits acute vaso-constriction in vivo. Environ Health Perspect 116:937-942.
40. Peters A, Skorkovsky J, Kotesovec F, Brynda J, Spix C, Wichmann HE, et al. 2000. Associations between mortality and air pollution in central Europe. Environ Health Perspect 108:283-287.
41. Peters A, von Klot S, Heier M, Trentinaglia I, Hormann A, Wichmann HE, et al. 2004. Exposure to traffc and the onset of myocardial infarction. New Eng J Med 351:1721-1730.
42. Phipps R P. 2000. Atherosclerosis: the emerging role of infam-mation and the CD40-CD40 ligand system. Proc Natl Acad Sci USA 97:6930-6932.
43. Pietropaoli A P, Frampton MW, Oberdorster G, Cox C, Huang L, Marder VJ, et al. 2004. Blood markers of coagulation and infammation in healthy human subjects exposed to carbon ultrafne particles. In: Effects of Air Contaminants on the Respiratory Tract-Interpretations from Molecular to Meta-Analysis (Heinrich U, ed). Stuttgart:INIS Monographs, Fraunhofer IRB Verlag, 181-194.
44. Pope CA III. 2009. The expanding role of air pollution in cardiovascular disease: does air pollution contribute to risk of deep vein thrombosis? Circulation 119:3050-3052.
45. Pope CA III, Burnett RT, Thurston GD, Thun MJ, Calle EE, Drewski D, et al. 2004. Cardiovascular mortality and long-term exposure to particulate air pollution. Circulation 109:71-77.
46. Radomski A, Jurasz P, Alonso-Escolano D, Drews M, Morandi M, Malinski T, et al. 2005. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 146:882-893.
47. Roldán V, Marin F, Garcia-Herola A, Lip G Y. 2005. Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk strati-fcation scores in atrial fbrillation. Thromb Res 116:321-325.
48. Rückerl R, Phipps R P, Schneider A, Frampton M, Cyrys J, Oberdörster G, et al. 2007. Ultrafne particles and platelet activation in patients with coronary heart disease-results from a prospective panel study. Part Fibre Toxicol 4:1-14.
49. Sambola A, Osende J, Hathcock J, Degen M, Nemerson Y, Fuster V, et al. 2003. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 107:973-977.
50. Samet, JM, Rappold A, Graff D, Cascio WE, Berntsen JH, Huang YC, et al. 2009. Concentrated ambient ultrafne particle exposure induces cardiac changes in young healthy volunteers. Am J Respir Crit Care Med 179:1034-1042.
51. Schneider A, Neas L, Herbst MC, Case M, Williams RW, Cascio W, et al. 2008. Endothelial dysfunction: associations with exposure to ambient fne particles in diabetic individuals. Environ Health Perspect 116:1666-1674.
52. Schönbeck U U, Varo N, Libby P, Buring J, Ridker PM. 2001. Soluble CD40L and cardiovascular risk in women. Circulation 104:2266-2268.
53. Shah A, Pietropaoli A P, Frasier LM, Speers DM, Chalupa DC, Delehanty JM, et al. 2008. Effect of inhaled carbon ultra-fine particles on reactive hyperemia in healthy human subjects. Environ Health Perspect 116:375-380.
54. Simak J, Gelderman M P. 2006. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 20:1-26.
55. Stumpf C, Lehner C, Eskaf S, Raaz D, Yilmaz A, Ropers S, et al. 2003. Enhanced levels of CD154 (CD40 ligand) on platelets in patients with chronic heart failure. Eur J Heart Fail 5(5):629-637.
56. Utell MJ, Frampton MW, Zareba W, Devlin RB, Cascio WE. 2002. Cardiovascular effects associated with air pollution: potential mechanisms and methods of testing. Inhal Toxicol 14:1231-1247.
57. Zanobetti A, Schwartz J. 2002. Cardiovascular damage by airborne particles: are diabetics more susceptible? Epidemiology 13:588-592.
58. Zareba W, Pancio G, Moss AJ, Kalaria VG, Marder VJ, Weiss HJ, et al. 2001. Increased level of von Willebrand factor is signifcantly and independently associated with diabetes in postinfarction patients. Thromb Haemost 86:791-799.